These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27295823)

  • 1. [Efficacy of the Serigaya Methamphetamine Relapse Prevention Program (SMARPP): for patients with drug use disorder: A study on factors influencing 1-year follow-up outcomes].
    Tanibuchi Y; Matsumoto T; Imamura F; Wakabayashi A; Kawachi H; Hikitsuchi E; Takano A; Yonezawa M; Kato T; Yamada M; Wachi A; Aboshi M; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Feb; 51(1):38-54. PubMed ID: 27295823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Response to treatment of patients abusing the "dappou drug" who participated in a group relapse prevention program: a comparison with patients abusing methamphetamine].
    Hikitsuchi E; Matsumoto T; Wada K; Tanibuchi Y; Takano A; Imamura F; Kawachi H; Wakabayashi A; Kato T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Dec; 49(6):318-29. PubMed ID: 25831947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigating actual conditions to clarify issues accompanying SMARPP].
    Kondo C; Takano A; Matsumoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2015 Apr; 50(2):66-87. PubMed ID: 26255432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A preliminary study on outpatient relapse prevention program for methamphetamine dependent patients: Serigaya Methamphetamine Relapse Prevention Program (SMARPP)].
    Kobayashi O; Matsumoto T; Otsuki M; Endo K; Okudaira K; Harai H; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2007 Oct; 42(5):507-21. PubMed ID: 18051470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development and evaluation of a relapse prevention tool for drug-abusing delinquents incarcerated in a juvenile classification home: a self-teaching workbook for adolescents, the "SMARPP-Jr].
    Matsumoto T; Imamura F; Kobayashi O; Chiba Y; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Jun; 44(3):121-38. PubMed ID: 19618838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness evaluation of Serigaya Methamphetamine Relapse Prevention Program in drug addiction rehabilitation center.
    Kondo A; Kuritsubo C; Shirakawa Y; Matsumoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Dec; 51(6):414-424. PubMed ID: 30461249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treating drug dependent patients through outpatient group therapy-Serigaya Methamphetamine Relapse Prevention Program (SMARPP)].
    Kobayashi O
    Seishin Shinkeigaku Zasshi; 2010; 112(9):877-84. PubMed ID: 21077296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
    Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Web-based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: protocol for a multicenter randomized controlled trial in Japan.
    Takano A; Miyamoto Y; Kawakami N; Matsumoto T; Shinozaki T; Sugimoto T
    BMC Psychiatry; 2016 Apr; 16():87. PubMed ID: 27044304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Treatment for Drug Dependence not Requiring Specialists: A Treatment Program based on a Workbook, the "SMARPP"].
    Matsumoto T
    Seishin Shinkeigaku Zasshi; 2015; 117(8):655-62. PubMed ID: 26642733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvement in the therapeutic attitudes of health care professionals who offer cognitive behavioral therapy towards substance abusers].
    Takano A; Kawakami N; Miyamoto Y; Matsumoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Feb; 49(1):28-38. PubMed ID: 24818356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors associated with dropout from a group cognitive behavioral therapy for substance use disorder].
    Iwano S; Takahashi Y; Masuyama K; Yoshinari Y; Horiuchis S; Yanbe K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2013 Dec; 48(6):415-25. PubMed ID: 24660557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What is the Japanese mental health service lacking for drug dependence rehabilitation?].
    Matsumoto T; Kobayashi O
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):172-87. PubMed ID: 18646643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling the laxative abuse of anorexia nervosa patients with the Serigaya Methamphetamine Relapse Prevention Program workbook: a case report.
    Toyoshima K; Kusumi I
    Biopsychosoc Med; 2019; 13():23. PubMed ID: 31660062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible effectiveness of intervention using a self-teaching workbook in adolescent drug abusers detained in a juvenile classification home.
    Matsumoto T; Chiba Y; Imamura F; Kobayashi O; Wada K
    Psychiatry Clin Neurosci; 2011 Oct; 65(6):576-83. PubMed ID: 22003990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current situation and clinical characteristics of sedative-related disorder patients in Japan: a comparison with methamphetamine-related disorder patients].
    Matsumoto T; Ozaki S; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2011; 113(12):1184-98. PubMed ID: 22352004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a web-based relapse prevention program on abstinence among Japanese drug users: A pilot randomized controlled trial.
    Takano A; Miyamoto Y; Shinozaki T; Matsumoto T; Kawakami N
    J Subst Abuse Treat; 2020 Apr; 111():37-46. PubMed ID: 32087837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a relapse-prevention program for methamphetamine-dependent inmates using a self-teaching workbook and group therapy.
    Matsumoto T; Imamura F; Kobayashi O; Wada K; Ozaki S; Takeuchi Y; Hasegawa M; Imamura Y; Taniya Y; Adachi Y
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):61-9. PubMed ID: 24102922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.